CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Thousands		Total	Common Stock	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2024			119,143,782
Beginning balance at Dec. 31, 2024		$ 6,857,478	$ 3,121,617	$ (3,323)	$ 3,666,959	$ (30,942)	$ 103,167
Beginning balance (in shares) at Dec. 31, 2024				(46,968)
Increase (Decrease) in Shareholders' Equity
Net income (loss)		(338)			(4,644)		4,306
Other comprehensive income		848				848
Issuance of common stock (in shares)	[1]		301,517
Issuance of common stock	[1]	(12,005)	$ (12,005)
Other		(1)			(2)		1
Ending balance (in shares) at Mar. 31, 2025			119,445,299
Ending balance at Mar. 31, 2025		$ 6,845,982	$ 3,109,612	$ (3,323)	3,662,313	(30,094)	107,474
Ending balance (in shares) at Mar. 31, 2025				(46,968)
Beginning balance (in shares) at Dec. 31, 2025		120,950,839	120,950,839
Beginning balance at Dec. 31, 2025		$ 7,087,075	$ 3,231,372	$ (3,323)	3,850,817	(32,408)	40,617
Beginning balance (in shares) at Dec. 31, 2025		(46,968)		(46,968)
Increase (Decrease) in Shareholders' Equity
Net income (loss)		$ 35,114			32,920		2,194
Other comprehensive income		459				459
Issuance of common stock (in shares)	[2]		282,790
Issuance of common stock	[2]	(11,681)	$ (11,681)
Other		$ 1			1
Ending balance (in shares) at Mar. 31, 2026		121,233,629	121,233,629
Ending balance at Mar. 31, 2026		$ 7,110,968	$ 3,219,691	$ (3,323)	$ 3,883,738	$ (31,949)	$ 42,811
Ending balance (in shares) at Mar. 31, 2026		(46,968)		(46,968)

[1] See Note 13 for information related to our equity forward sale agreements.

[2] See Note 13 for information related to our equity forward sale agreements.